-
A very large prospective study found no evidence that nuts, corn, popcorn, or seeds increased diverticular disease or its complications.
-
A randomized controlled trial of newly diagnosed type 2 diabetic patients not on insulin showed an increased depression score in those performing home glucose monitoring and no improvement in glycemic control.
-
A short-acting dihydropyridine calcium channel blocker with a rapid onset of action has been approved for intravenous use to reduce blood pressure.
-
The established causal relationship between endothelial dysfunction and erectile dysfunction (ED) provides mechanistic insight into an obesity-sexual health linkage.
-
The ECG shown was interpreted as showing sinus rhythm with blocked premature atrial contractions (PACs) as the reason for the slow rate.
-
Guidelines for prediabetes from The American College of Endocrinology; statins for the prevention of dementia? Possible help for women suffering from sexual side effects while on antidepressants; government incentives for electronic prescribing; FDA Actions.
-
Over a 5-year period, 16% of elderly people developed mild cognitive impairment (MCI) and had double the risk of developing Alzheimer's disease (AD) than normals; however, 30% with MCI reverted to normal.
-
Women who do not take supplemental calcium frequently need more education, and state they would be positively influenced by their physician's recommendations.
-
Regular ingestion of caffeine, either as coffee, tea or chocolate was followed in 2 large cohorts of men and women for more than two decades. When caffeine was consumed regularly, there was no increase in the overall mortality. Indeed, a modest benefit of caffeine consumption was noted on overall mortality and in particular death related to cardiovascular disorders. This effect was more pronounced in women.
-
Women who had sexual dysfunction that was believed to be a side effect of antidepressants were more likely to report improved sexual function if they were assigned to the sildenafil, rather than to the placebo arm of a placebo-controlled trial.
